![Michael Kavanagh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 3 M $ al 31/08/2026
Michael Kavanagh is President, CEO, MD & Executive Director at Nanosonics Ltd. since 2013.
Mr. Kavanagh was Senior Vice President-Global Marketing at Cochlear Ltd. from 2003 to 2013.
Mr. Kavanagh earned an MBA from The University of Queensland and completed undergraduate studies at University College Dublin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NANOSONICS LIMITED 0,48 % | 11/12/2025 | 1.432.788 ( 0,48 % ) | 3 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NANOSONICS LIMITED | Director Ejecutivo | 21/10/2013 |
| Empresas | Cargo | Fin |
|---|---|---|
| COCHLEAR LIMITED | Ventas & Marketing | 01/10/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Nanosonics Ltd.
 Nanosonics Ltd. Medical SpecialtiesHealth Technology Engages in the research, development and commercialization of infection control and decontamination products and related technologies | Health Technology |
Cochlear Ltd.
 Cochlear Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets implantable hearing solutions | Health Technology |
The University of Queensland
 The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
